Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)

Clinical trial NCT01472939 · COMPLETED

Trial details

NCT number: NCT01472939
Sponsor: Shire
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease

Start date: 2012-02-27
Primary completion: 2013-05-14
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.